Podcast Episodes
Back to Search
Legal Matters: Musk vs. Altman Day Three
In this episode, we examine the key events from day three of the Musk-Altman trial. We also evaluate the implications of the Anthropic reversal by th…
5 months, 2 weeks ago
OpenAI Conflict: Altman at Odds with CFO
In this episode, we examine the conflict between Altman and the CFO of OpenAI. We also discuss the EU's suspension of the AI Act and Google's interna…
5 months, 3 weeks ago
OpenAI Charts Its Own Course Away from Microsoft
In this episode, we discuss how OpenAI is charting its own course away from Microsoft. We also delve into the innovative $1.1 billion funding initiat…
5 months, 3 weeks ago
ChatGPT 5.5: Key Takeaways
In this episode, we present our key takeaways from the ChatGPT 5.5 launch. We'll also highlight SpaceX's plans for GPU production.
5 months, 3 weeks ago
Voices Discussing Google’s AI Strategy
In this episode, we bring together voices discussing the implications of Google’s AI strategy highlighted at Cloud Next. Join us for diverse perspect…
5 months, 3 weeks ago
New Apple CEO, OpenAI's New Image Model, Vercel AI Hack
In this episode, we explore the significant leadership change at Apple as Tim Cook steps down and John Tarnas takes the helm, amid ongoing challenges…
5 months, 4 weeks ago
Anthropic's Revenue Exceeds OpenAI's
In this episode, we highlight the recent revenue achievements of Anthropic. Discover how this affects the broader digital landscape.
5 months, 4 weeks ago
Anthropic’s Claude: A New Design in AI
In this episode, we cover the launch of Claude, a compelling new design from Anthropic. Listen in to learn about its unique features and potential us…
6 months ago
Anthropic Ships Opus 4.7, $2B With No Product & Google AI Deals
Anthropic dropped Claude Opus 4.7 today, but the bigger story is the model they didn't release. We break down Project Glasswing, why Mythos stays loc…
6 months ago
Anthropic's IPO Play, Novo Nordisk x OpenAI, and the First Brain Sensor Goes Human
Anthropic adds the Novartis CEO to its board as it gears up for an IPO — and on the same day, Novo Nordisk partners with OpenAI to supercharge drug d…
6 months ago